Navigation Links
Lumena Pharmaceuticals Launches Global Clinical Program to Evaluate Safety and Efficacy of LUM001 in Children with Alagille Syndrome
Date:9/26/2013

tric patients have very little relief from the aggravating symptoms, and the need for treatment options is pressing."

"LUM001 represents a potential new approach to treating the progressive liver damage and symptoms associated with Alagille syndrome that severely affect a patient's quality of life," explained Benjamin Shneider, M.D., Pediatric Hepatologist, Children's Hospital of Pittsburgh of UPMC, the ITCH study chair. "Currently, there are no approved drugs to treat the cholestasis and pruritus associated with ALGS, and frequent options for children suffering with this disease are off-label treatments with limited efficacy and potential liver toxicity or surgical diversion of bile, which comes with risk of complications and quality of life issues."

The ITCH study is a multi-center U.S.-based study which is expected to begin later in 2013 and will be seeking pediatric patients, two years of age and older, with ALGS. The ITCH study is being conducted in collaboration with the Childhood Liver Disease Research and Education Network (ChiLDREN), a collaborative research network supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a part of the National Institutes of Health (NIH),which has a Cooperative Research and Development Agreement (CRADA) with Lumena. Lumena and ChiLDREN are also collaborating with European investigators to evaluate LUM001 in patients with progressive familial intrahepatic cholestasis (PFIC), another rare cholestatic liver disease.

"This public/private partnership is an example of a fruitful collaboration to find treatments for rare diseases," said Edward Doo, M.D., director of the Liver Diseases Research Program at NIDDK. "These cholestatic liver diseases have devastating symptoms and there is a significant need for additional treatment options, especially for children."

Patients that complete either the IMAGO or ITCH study w
'/>"/>

SOURCE Lumena Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ampio Pharmaceuticals, Inc. Announces $25 Million Financing
2. KaloBios Pharmaceuticals, Inc. Prices Public Offering of Common Stock
3. SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. -- AMAG
4. Anthera Pharmaceuticals Announces Emerging Data from Phase 2 Open-Label Extension Study to be Presented at the ACR/ARHP 2013 Annual Scientific Meeting
5. Isis Pharmaceuticals to Present at the Leerink Swann Rare Disease Roundtable
6. Edison Pharmaceuticals Announces Initiation of NIH-Sponsored EPI-743 Clinical Trial with NIH Undiagnosed Diseases Program Patients
7. Inovio Pharmaceuticals Targets Transformation of Monoclonal Antibody Therapies
8. Servier Voluntary Public Offer for all Outstanding Shares of Egis Pharmaceuticals PLC
9. Boehringer Ingelheim Pharmaceuticals, Inc. colabora con Univision Communications Inc. para lanzar una campaña integrada en español
10. Boehringer Ingelheim Pharmaceuticals, Inc. Collaborates With Univision Communications Inc. To Launch An Integrated Campaign In Spanish
11. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015 San MediTech, the ... continuous glucose monitoring (CGM) for diabetics, announced its plan ... Sessions in Boston on June ... their newest Dynamic Glucose Monitoring System (DGMS). The company ... the world the innovative technologies and advancements made by ...
(Date:6/2/2015)... Mass. , June 2, 2015  PROMETRIKA, ... expanded its offerings with the addition of pharmacovigilance ... a world leader in safety data collection and ... and regulatory affairs professionals, and expert physicians, each ... provide clinical interpretation and monitoring of safety trends. ...
(Date:6/2/2015)... June 2, 2015  Psychemedics Corporation (NASDAQ: PMD ... twenty-five years, announced the addition of 2 new drugs ... growing abuse concerns, the addition of Oxymorphone was made ... added as an option to the Amphetamine panel. ... stated:  "Sadly, more and more prescription drugs are being ...
Breaking Medicine Technology:San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 2San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 3San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 4PROMETRIKA Announces the Availability of Pharmacovigilance Services 2Psychemedics Announces Addition Of FDA Cleared Drugs 2Psychemedics Announces Addition Of FDA Cleared Drugs 3
... on the success of their revolutionary soft cloth nasal ... proud to introduce a mask tube so lightweight and ... Used in the treatment of sleep apnea, ... the CPAP mask with a 15-millimeter hose composed of ...
... 2011 Ampio Pharmaceuticals, Inc. (NASDAQ: ... that discovers and develops new uses for previously ... announced that an IRB approved, randomized, vehicle-controlled, double-blinded ... in Denver, Colorado indicates that Ampion™ provides safe ...
Cached Medicine Technology:Circadiance Launches Revolutionary New CPAP Tube 2Ampio Pharmaceuticals Announces Positive Results on Ampion™ Trial for Relief of Nasal Inflammation 2Ampio Pharmaceuticals Announces Positive Results on Ampion™ Trial for Relief of Nasal Inflammation 3
(Date:6/2/2015)... 02, 2015 For those that have ... exposed to harmful germs, chemicals and bodily fluids from ... to an inventor from Queens Village, N.Y., their worries ... an efficient, fun, hygienic way to store and dispense ... to bugs, chemicals and germs. Furthermore, it insures that ...
(Date:6/2/2015)... NC (PRWEB) June 02, 2015 ... training and compliance solutions for the healthcare market, ... The Arc to offer 10 complimentary courses relating ... provide public safety professionals with additional resources to ... Safety professionals are often the first responders to ...
(Date:6/2/2015)... 02, 2015 Recent findings from the ... while there has been a reduction in conventional cigarette ... waterpipe vapor (hookah) usage has doubled among today’s teens ... Russell Gombosi believes the national trend is consistent with ... 15 to 20 years to fully determine the long-term ...
(Date:6/2/2015)... Glidewell Laboratories, industry-leading provider of ... the new issue of Chairside® magazine, its restorative-dentistry-focused ... The digital edition of the latest issue, Volume ... of the dental laboratory’s magazine, can be viewed ... by visiting http://www.chairsidemagazine.com . , In the ...
(Date:6/2/2015)... 02, 2015 Residents of Monarch Landing ... swim, take a fitness class, do yoga, play volleyball, ... In preparation for the Alzheimer’s Association’s Walk to End ... will take part in a challenge to exercise for ... Landing’s management company. , While the walk will raise ...
Breaking Medicine News(10 mins):Health News:Dental Storage and Dispensing Unit Invented by InventHelp Client (LGI-1890) 2Health News:Relias Learning Partners with Behavioral Health and Developmental Disabilities Leaders to Offer Complimentary Resources to Public Safety Professionals 2Health News:Relias Learning Partners with Behavioral Health and Developmental Disabilities Leaders to Offer Complimentary Resources to Public Safety Professionals 3Health News:Susquehanna Health Pediatrician Warns of Adverse Effects of Teen E-Cigarette Usage 2Health News:Susquehanna Health Pediatrician Warns of Adverse Effects of Teen E-Cigarette Usage 3Health News:Glidewell Laboratories Releases New Issue of Restorative Dentistry Magazine Chairside in Print and Online 2Health News:Glidewell Laboratories Releases New Issue of Restorative Dentistry Magazine Chairside in Print and Online 3Health News:Monarch Landing Takes 60-Day Exercise Challenge to Combat Alzheimer’s 2Health News:Monarch Landing Takes 60-Day Exercise Challenge to Combat Alzheimer’s 3
... intimate partners spent 42 percent more on health care per ... more than 3,000 women. , And the costs don,t end ... suffered physical abuse five or more years earlier still spent ... who were never abused. , "Along with all the physical ...
... Services, Inc. announced today that it has provided ... Hospital in Mountain View, California. The five-year tax-exempt ... Siemens Medical Solutions equipment which will be deployed ... http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO )"For more than 40 years, ...
... Kiley Carlson of Sioux City, IA will travel to ... 2009 to meet with congressional leaders and gain their ... toward a cure for epilepsy.Carlson, 16, is one of ... Kids Speak Up! , a national program coordinated ...
... 23 Fujirebio Diagnostics, Inc., the premier cancer ... biomarker assays, today announced the appointment of Grady ... Barnes comes to Fujirebio Diagnostics with 25 years ... positions at Abbott and Meridian Bioscience, most recently ...
... demonstrated how a single-celled organism, living freely in the ... transmission to animals and humans. , Salmonella ... food type, causing diarrhoea, abdominal pain and fever. ... also cause typhoid fever has evolved unique mechanisms ...
... access to largest portfolio of clinical laboratory ... Healthcare ( www.siemens.com/diagnostics ) and Sysmex Corporation ... of a five-year contract renewal for a ... Under the agreement, clinical laboratory customers around ...
Cached Medicine News:Health News:Physical abuse raises women's health costs over 40 percent 2Health News:Siemens Financial Services, Inc. Announces Completion of Tax-Exempt Financing With El Camino Hospital 2Health News:Siemens Financial Services, Inc. Announces Completion of Tax-Exempt Financing With El Camino Hospital 3Health News:Iowa Youth Shares Epilepsy Message on Capitol Hill 2Health News:Fujirebio Diagnostics Appoints Grady Barnes as Chief Scientific Officer 2Health News:Study shows how Salmonella survives in environment 2Health News:Siemens and Sysmex Renew Global Agreement 2Health News:Siemens and Sysmex Renew Global Agreement 3
... a monoclonal antibody based colorimetric test ... Neisseria gonorrhoeae. The test requires less ... no heating or pretreatment. The test ... fresh cultures. GonoGen&trade II eliminates agglutination, ...
Culture Confirmation Tests...
... GC is a novel device for ... Neisseria gonorrhoeae and Neisseria meningitidis. ... life and is easily transportable as ... inoculate, incubate and examine the growth ...
... (Nidek Advanced Vision Information System) is an ... software on a platform designed to communicate ... The network can be expanded in various ... to Nidek products but also to fundus ...
Medicine Products: